Favorites Sign in
  1. Home
  2. Companies
  3. Stock Protalix BioTherapeutics
Protalix BioTherapeutics logo

Protalix BioTherapeutics PLX

$ 2.71 0.37%
report update icon

Quarterly report 2026-Q2
added 08-12-2026

Country

 israelIsrael

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NYSE AMERICAN

Shares

 78.5 M

Market Cap[1]

 $ 213 M

EBITDA (LTM)

 $ -4.04 M

P/E (LTM)

 -33.375

P/S (LTM)

 3.976157

EPS (LTM)

 -0.08

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Zoetis Zoetis
ZTS
 		$ 71.41 2.45 % $ 31.7 B NYSE,SPB usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
 		$ 3.22 1.09 % $ 20.6 B Nasdaq Capital Market australiaAustralia
Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Limited
RDY
 		$ 12.32 0.57 % $ 10.3 B NYSE indiaIndia
Mirati Therapeutics Mirati Therapeutics
MRTX
 		- - $ 3.3 B Nasdaq Global Select Market,SPB usaUSA
Gritstone Oncology Gritstone Oncology
GRTS
 		- 0.42 % $ 213 M Nasdaq Global Select Market usaUSA
NexImmune NexImmune
NEXI
 		- 70.13 % $ 4.12 M Nasdaq Global Market usaUSA
Harpoon Therapeutics Harpoon Therapeutics
HARP
 		- - $ 763 M Nasdaq Global Select Market usaUSA
InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.
NVIV
 		- -37.48 % $ 476 K Nasdaq Capital Market usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
 		- -19.68 % $ 18.4 M Nasdaq Capital Market canadaCanada
ObsEva SA ObsEva SA
OBSV
 		- -15.52 % $ 10.5 M Nasdaq Global Select Market schweizSchweiz
HOOKIPA Pharma HOOKIPA Pharma
HOOK
 		- -6.92 % $ 79.4 M Nasdaq Global Select Market usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
 		- -0.31 % $ 3.64 M Nasdaq Capital Market usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
 		- - $ 109 M Nasdaq Global Select Market usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
 		- 1.02 % $ 90.8 M Nasdaq Global Select Market britainBritain
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
 		- - $ 154 M Nasdaq Capital Market usaUSA
Oyster Point Pharma Oyster Point Pharma
OYST
 		- - $ 300 M Nasdaq Global Select Market usaUSA
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
 		- - $ 643 M Nasdaq Global Select Market,SPB usaUSA
9 Meters Biopharma 9 Meters Biopharma
NMTR
 		- -42.97 % $ 1.05 M Nasdaq Global Select Market usaUSA
Otonomy Otonomy
OTIC
 		- -1.96 % $ 4.68 M Nasdaq Global Select Market usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
 		- - $ 2.6 B Nasdaq Global Select Market usaUSA
Kaleido Biosciences Kaleido Biosciences
KLDO
 		- -3.69 % $ 12.4 M Nasdaq Global Select Market usaUSA
Kronos Bio Kronos Bio
KRON
 		- 1.49 % $ 50.8 M Nasdaq Global Select Market usaUSA
Landos Biopharma Landos Biopharma
LABP
 		- 0.58 % $ 144 M Nasdaq Global Market usaUSA
PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals
PHAS
 		- 7.4 % $ 6.29 M Nasdaq Global Market usaUSA
Provention Bio Provention Bio
PRVB
 		- - $ 2.37 B Nasdaq Global Select Market usaUSA
Poseida Therapeutics Poseida Therapeutics
PSTX
 		- - $ 857 M Nasdaq Global Select Market usaUSA
PolarityTE PolarityTE
PTE
 		- -0.82 % $ 1.78 M Nasdaq Capital Market usaUSA
Atreca Atreca
BCEL
 		- -11.76 % $ 5.79 M Nasdaq Global Select Market usaUSA
Reata Pharmaceuticals Reata Pharmaceuticals
RETA
 		- - $ 6.29 B Nasdaq Global Market,SPB usaUSA
Lumos Pharma Lumos Pharma
LUMO
 		- - $ 35.3 M Nasdaq Global Select Market usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
 		- - $ 23.9 M Nasdaq Global Select Market usaUSA
Satsuma Pharmaceuticals Satsuma Pharmaceuticals
STSA
 		- -0.9 % $ 36.5 M Nasdaq Global Market usaUSA
89bio 89bio
ETNB
 		- - $ 1.55 B Nasdaq Global Market usaUSA
Syros Pharmaceuticals Syros Pharmaceuticals
SYRS
 		- -8.44 % $ 3.4 M Nasdaq Global Select Market usaUSA
SpringWorks Therapeutics SpringWorks Therapeutics
SWTX
 		- - $ 3.48 B Nasdaq Global Select Market,SPB usaUSA
Trevena Trevena
TRVN
 		- -46.58 % $ 31.8 M Nasdaq Capital Market usaUSA
Oncorus Oncorus
ONCR
 		- -8.54 % $ 3.19 M Nasdaq Global Market usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
 		- 31.87 % $ 1.61 M Nasdaq Global Select Market usaUSA
Y-mAbs Therapeutics Y-mAbs Therapeutics
YMAB
 		- - $ 382 M Nasdaq Global Select Market,SPB usaUSA
Oncternal Therapeutics Oncternal Therapeutics
ONCT
 		- -24.12 % $ 1.56 M Nasdaq Capital Market usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
 		- -2.99 % $ 2.47 M NYSE American usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
BELLUS Health BELLUS Health
BLU
 		- - $ 2.47 B Nasdaq Global Select Market canadaCanada
bluebird bio bluebird bio
BLUE
 		- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
 		- - $ 13.6 B Nasdaq Global Select Market,SPB usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
 		- - $ 35.4 M Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
 		- -0.13 % $ 3.73 B Nasdaq Global Select Market,SPB usaUSA
Epizyme Epizyme
EPZM
 		- - $ 249 M Nasdaq Global Select Market usaUSA
Forward Pharma A/S Forward Pharma A/S
FWP
 		- -0.75 % $ 18.7 M Nasdaq Capital Market danmarkDanmark

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.